Patents Assigned to WUHAN THERASOURCE BIOSCIENCES INC
  • Anti-BLyS antibody
    Patent number: 9828423
    Abstract: The present invention belongs to the field of biopharmaceutics. Disclosed is an anti-BLyS antibody. The anti-BLyS antibody specifically targets BLyS, can combine with a B lymphocyte stimulating factor, and can inhibit the combination of the B lymphocyte stimulating factor with the receptor BR3-Fc thereof. Also provided are uses of the anti-BLyS antibody in the manufacture of a medicament for preventing and/or treating diseases caused by the excessive proliferation of B cells such as systemic lupus erythematorsus.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: November 28, 2017
    Assignees: WUHAN THERASOURCE BIOSCIENCES INC., SHANGHAI JUNSHI BIOSCIENCE CO., LTD.
    Inventors: Bo Chen, Hui Feng, Hongbing Shu
  • ANTI-BLYS ANTIBODY
    Publication number: 20150259409
    Abstract: The present invention belongs to the field of biopharmaceutics. Disclosed is an anti-BLyS antibody. The anti-BLyS antibody specifically targets BLyS, can combine with a B lymphocyte stimulating factor, and can inhibit the combination of the B lymphocyte stimulating factor with the receptor BR3-Fc thereof. Also provided are uses of the anti-BLyS antibody in the manufacture of a medicament for preventing and/or treating diseases caused by the excessive proliferation of B cells such as systemic lupus erythematosus.
    Type: Application
    Filed: May 22, 2013
    Publication date: September 17, 2015
    Applicants: WUHAN THERASOURCE BIOSCIENCES INC, SHANGHAI UNION BIOPHARM CO., LTD
    Inventors: Bo Chen, Hui Feng, Hongbing Shu